Year None202220212020201920182017 Potential Predictive Biomarkers for BXCL701 In Acute Myeloid Leukemia (AML) November 10, 2022 BXCL701 Combined with Pembrolizumab, in Patients with Metastatic Castration-Resistant Prostate Cancer of Small Cell Neuroendocrine Phenotype October 28, 2022 Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder February 22, 2022 BioXcel Therapeutics Presented Data at the 2022 ASCO Genitourinary Cancers Symposium BXCL701-201 Adeno Poster February 17, 2022 BioXcel Therapeutics Presented Data at the 2022 ASCO Genitourinary Cancers Symposium BXCL701-201 SCNC Poster February 17, 2022
BXCL701 Combined with Pembrolizumab, in Patients with Metastatic Castration-Resistant Prostate Cancer of Small Cell Neuroendocrine Phenotype October 28, 2022
Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder February 22, 2022
BioXcel Therapeutics Presented Data at the 2022 ASCO Genitourinary Cancers Symposium BXCL701-201 Adeno Poster February 17, 2022
BioXcel Therapeutics Presented Data at the 2022 ASCO Genitourinary Cancers Symposium BXCL701-201 SCNC Poster February 17, 2022
